Skip to main content

CPS Solutions, LLC Announces Acquisition of Trellis Rx, LLC, Offering End-To-End Suite of Products and Solutions Across Inpatient, Outpatient & Specialty Pharmacy

Written by Customer Service on . Posted in Mergers And Acquisitions.

  • Acquisition complements existing CPS portfolio, delivering a broader range of offerings, providing greater flexibility of services, structure, and support across inpatient, outpatient and specialty pharmacy settings, and ultimately accelerating growth for the benefit of patients and customers.
  • Both companies share a collective commitment to timely services, expanding access to critical medications, driving improved clinical performance, and creating a more streamlined and effective inpatient, outpatient and specialty pharmacy experience.

DUBLIN, Ohio, June 02, 2022 (GLOBE NEWSWIRE) — CPS Solutions, LLC (“CPS”), a leading provider of enterprise pharmacy solutions to hospitals and health systems, today announced it has closed its acquisition of Trellis Rx, LLC (“Trellis”), a leading technology-enabled specialty pharmacy services provider. The combined company will offer a broader range of offerings and provide greater flexibility of services, structure and support to better support patients and health and hospital systems alike. Financial terms of the transaction were not disclosed; the transaction was subject to customary closing conditions.

“We are excited to welcome Trellis to the CPS family,” said Chairman and CEO of CPS, Frank Segrave. “The opportunity to combine two successful, mission-driven organizations and deliver a broader range of end-to-end services for the betterment of patients, providers and payors is tremendous, and we look forward to delivering on customer needs, improving pharmacy performance, and delivering innovative solutions to more patients.”

Together, the companies will offer an end-to-end suite of products and solutions, provide access to a wider range of medications, leverage innovative software, analytics and services to support a more seamless pharmacy experience for patients, and drive improved efficiencies and cost savings for more customers. The combined entity will be uniquely positioned to support more clients of all sizes and types, ranging from small and midsize independent hospitals and academic health systems to large independent hospitals and health systems, helping create a more seamless operating experience, and driving improved pharmacy performance.

“Trellis and CPS complement each other and together, we can create a more diverse offering across inpatient, outpatient and specialty pharmacy settings for health and hospital systems serving communities of all sizes,” said Trellis Co-founder and CEO, Andy Maurer. “This is an exciting opportunity for Trellis and CPS and I look forward to joining CPS’ management team to help drive our success as a combined organization positioned for continued growth.”

“The combination of CPS and Trellis advances us toward our goal of becoming the leading end-to-end pharmacy services provider for hospitals and health systems nationwide,” said Phil Zaorski, partner at Frazier Healthcare Partners and member of CPS’ Board of Directors. “Trellis’ specialty pharmacy management offering and technology are an excellent addition to CPS’ growing specialty pharmacy services segment. We will continue to invest in the combined organization to further strengthen the Company’s leadership position.”

Transaction Details

The transaction was subject to regulatory review and customary closing conditions. The parties closed the transaction on June 1, 2022.

Both companies will continue to operate under their respective brands for the near-term.

Goodwin Procter LLP served as legal counsel to CPS Solutions, LLC. Kirkland & Ellis served as legal counsel and TripleTree and Cantor Fitzgerald & Co. served as financial advisors to Trellis.

About CPS Solutions, LLC
Founded nearly 50 years ago, CPS Solutions, LLC (CPS) is one of the nation’s largest providers of pharmacy and hospital services – employing over 2,000 pharmacy and healthcare professionals and servicing over 800 hospitals and healthcare facilities nationwide. CPS helps clients tackle complex problems through our suite of solutions across the care continuum. CPS solutions include inpatient pharmacy solutions and specialty and ambulatory pharmacy solutions, pharmacy consulting, 340B services, telepharmacy services, supply chain and materials management services, rehabilitation services, and more. CPS empowers healthcare organizations to achieve operational excellence, drive clinical quality, attain continuous regulatory compliance, and improve bottom-line performance – all while supporting staff, caregivers, patients and their communities. For more information, visit cps.com.

About Trellis Rx
Trellis Rx is a complete specialty pharmacy services solution for health systems looking to enhance the medication therapy experience and drive market-leading clinical outcomes for their patients with chronic and complex conditions. Working side-by-side with health systems, Trellis Rx delivers everything required to rapidly build and expand fully-integrated specialty pharmacy services through a performance-based partnership model designed to ensure results. To learn more about Trellis Rx, visit www.trellisrx.com.

Media Contacts

CPS Solutions, LLC
Edelman for CPS Solutions, LLC
CPS@edelman.com

Trellis Rx
Laurice Lambert, General Counsel
TrellisRx@edelman.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.